Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded
Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated
House DoD Report Provides $15 Million For Lung Cancer Screening
FDA Approves Votrient For Renal Cell Carcinoma
NCI Picks 11 Centers For Chemical Biology Consortium
IOM Report Says Smoking Bans Cut Heart Attack Risk
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment









